Frequently Asked Questions
The global cell separation technologies market was valued at USD 6.9 Billion in 2022.
The cell separation technologies market is expected to grow at a CAGR of 12.10% between 2023 and 2030, reaching USD 15.34 Billion in 2030.
Instruments is the leading segment by-products, holding over 43% share in value in 2022.
The oncology research segment governs the demand for cell separation technologies worldwide, holding a massive share of over 80% in 2022.
The gradient centrifugation segment will post the highest CAGR during the forecast period.
Asia Pacific is fueling the growth of the cell separation technologies industry, with over one-third share in 2022.
The top players include bio-rad Laboratories, inc., stemcell technologies inc, Becton, Dickinson and company, alfa laval corporate ab, danaher corporation., preselect gmbh, thermo fisher scientific, inc., merck kgaa, molten biotech inc., corning incorporated
The rising cell therapy usage, and the prevalence of chronic diseases, are the major market drivers.
Price of routine consumable replacements, calibration, and maintenance major market restraints.
The huge growth potential in Asia Pacific, Cell separation technologies will be more in demand as precision medicine gains more traction are the major opportunities in the cell separation technologies industry.